Announced details
Distribution and logistics of clinical laboratory reagents; stable supply
Alfresa Corporation, a subsidiary of the Company, will establish a study group with 正晃株式会社. Capital and personnel relationships: not disclosed.
Head office: Fukuoka, Fukuoka Prefecture; Representative Director and President: In Masatoshi (印正俊). Founded in 1950, the company is a specialist trading company for clinical laboratory reagents. It has established business relationships with medical institutions mainly throughout Kyushu and Okinawa, and provides stable supplies of reagents and equipment, system development, operational support, maintenance and other services.
Alfresa Corporation: Chiyoda-ku, Tokyo. 正晃株式会社: Fukuoka, Fukuoka Prefecture.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Clinical laboratory reagent wholesale business |
| Counterparty | 正晃株式会社 |
| Counterparty overview | Head office: Fukuoka, Fukuoka Prefecture; Representative Director and President: In Masatoshi (印正俊). Founded in 1950, the company is a specialist trading company for clinical laboratory reagents. It has established business relationships with medical institutions mainly throughout Kyushu and Okinawa, and provides stable supplies of reagents and equipment, system development, operational support, maintenance and other services. |
| Relationship with the Company | Alfresa Corporation, a subsidiary of the Company, will establish a study group with 正晃株式会社. Capital and personnel relationships: not disclosed. |
| Launch date | 1 June 2026 (the date on which the establishment of the study group was decided; the start date of its activities: not disclosed) |
| Applicable area | Distribution and logistics of clinical laboratory reagents; stable supply |
| Location | Alfresa Corporation: Chiyoda-ku, Tokyo. 正晃株式会社: Fukuoka, Fukuoka Prefecture. |
| Location scale | Alfresa Corporation procures products from approximately 1,000 manufacturers in Japan and overseas and supplies them through approximately 170 locations nationwide. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The stable supply of clinical laboratory reagents and the efficiency and sophistication of the industry’s supply chain have become common challenges against a backdrop of expanding and increasingly advanced demand for clinical testing, as well as rising raw material and logistics costs.